186 related articles for article (PubMed ID: 27206930)
1. Consensus between the American College of Cardiology and the National Lipid Association on the use of non-statin therapy for atherosclerotic cardiovascular disease prevention.
Orringer CE; Morris PB
J Clin Lipidol; 2016; 10(3):458-61. PubMed ID: 27206930
[No Abstract] [Full Text] [Related]
2. Initiation Patterns of Statins in the 2 Years After Release of the 2013 American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Management Guideline in a Large US Health Plan.
Olufade T; Zhou S; Anzalone D; Kern DM; Tunceli O; Cziraky MJ; Willey VJ
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28473405
[TBL] [Abstract][Full Text] [Related]
3. American College of Cardiology/American Heart Association (ACC/AHA) Class I Guidelines for the Treatment of Cholesterol to Reduce Atherosclerotic Cardiovascular Risk: Implications for US Hispanics/Latinos Based on Findings From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
Qureshi WT; Kaplan RC; Swett K; Burke G; Daviglus M; Jung M; Talavera GA; Chirinos DA; Reina SA; Davis S; Rodriguez CJ
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28495699
[TBL] [Abstract][Full Text] [Related]
4. Medicare Formulary Changes After the 2013 American College of Cardiology/American Heart Association Cholesterol Guideline.
Dhruva SS; Desai NR; Karaca-Mandic P; Shah ND; Ross JS
J Am Coll Cardiol; 2017 Jan; 69(2):244-246. PubMed ID: 28081832
[No Abstract] [Full Text] [Related]
5. 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents.
; Lloyd-Jones DM; Morris PB; Ballantyne CM; Birtcher KK; Daly DD; DePalma SM; Minissian MB; Orringer CE; Smith SC
J Am Coll Cardiol; 2016 Jul; 68(1):92-125. PubMed ID: 27046161
[No Abstract] [Full Text] [Related]
6. 2015 ACC/AHA Focused Update of Secondary Prevention Lipid Performance Measures: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.
; Drozda JP; Ferguson TB; Jneid H; Krumholz HM; Nallamothu BK; Olin JW; Ting HH; ; Heidenreich PA; Albert NM; Chan PS; Curtis LH; Ferguson TB; Fonarow GC; Ho PM; O'Brien S; Russo AM; Thomas RJ; Ting HH; Varosy PD
Circ Cardiovasc Qual Outcomes; 2016 Jan; 9(1):68-95. PubMed ID: 26666514
[No Abstract] [Full Text] [Related]
7. Heterogeneity in statin indications within the 2013 american college of cardiology/american heart association guidelines.
Shah RV; Rubenfire M; Brook RD; Lima JA; Nallamothu B; Murthy VL
Am J Cardiol; 2015 Jan; 115(1):27-33. PubMed ID: 25456869
[TBL] [Abstract][Full Text] [Related]
8. Nontraditional Markers of Cardiovascular Disease Risk Can Improve the 2013 American College of Cardiology/American Heart Association Prevention Guidelines: Insights From the Multi-Ethnic Study of Atherosclerosis Investigation.
Superko HR
Circulation; 2015 Sep; 132(10):904-6. PubMed ID: 26224807
[No Abstract] [Full Text] [Related]
9. The 2013 American College of Cardiology/American Heart Association guidelines on treating blood cholesterol and assessing cardiovascular risk: a busy practitioner's guide.
Gupta A; Smith DA
Endocrinol Metab Clin North Am; 2014 Dec; 43(4):869-92. PubMed ID: 25432387
[TBL] [Abstract][Full Text] [Related]
10. Race and Socioeconomic Differences Associated With Changes in Statin Eligibility Under the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines.
Verma AA; Jimenez MP; Subramanian SV; Sniderman AD; Razak F
Circ Cardiovasc Qual Outcomes; 2017 Sep; 10(9):. PubMed ID: 28912201
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of the American College of Cardiology/American Heart Association statin eligibility groups, statin use, and low-density lipoprotein cholesterol control in US adults using the National Health and Nutrition Examination Survey 2011-2012.
Wong ND; Young D; Zhao Y; Nguyen H; Caballes J; Khan I; Sanchez RJ
J Clin Lipidol; 2016; 10(5):1109-18. PubMed ID: 27678427
[TBL] [Abstract][Full Text] [Related]
12. Implications of American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus Among Several US Networks of Community Health Centers.
Akhabue E; Rittner SS; Carroll JE; Crawford PM; Dant L; Laws R; Leo MC; Puro J; Persell SD
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28673901
[TBL] [Abstract][Full Text] [Related]
13. Perspective on the 2013 American Heart Association/American College of Cardiology guideline for the use of statins in primary prevention of low-risk individuals.
Breslow JL
Circ Res; 2014 Feb; 114(5):758-60. PubMed ID: 24577963
[No Abstract] [Full Text] [Related]
14. 2013 ACC/AHA cholesterol treatment guideline: what was done well and what could be done better.
Martin SS; Abd TT; Jones SR; Michos ED; Blumenthal RS; Blaha MJ
J Am Coll Cardiol; 2014 Jun; 63(24):2674-8. PubMed ID: 24681146
[TBL] [Abstract][Full Text] [Related]
15. New cholesterol guidelines for the management of atherosclerotic cardiovascular disease risk: a comparison of the 2013 American College of Cardiology/American Heart Association cholesterol guidelines with the 2014 National Lipid Association recommendations for patient-centered management of dyslipidemia.
Adhyaru BB; Jacobson TA
Cardiol Clin; 2015 May; 33(2):181-96. PubMed ID: 25939292
[TBL] [Abstract][Full Text] [Related]
16. A Comparative Analysis of Current Lipid Treatment Guidelines: Nothing Stands Still.
Tibrewala A; Jivan A; Oetgen WJ; Stone NJ
J Am Coll Cardiol; 2018 Feb; 71(7):794-799. PubMed ID: 29447742
[TBL] [Abstract][Full Text] [Related]
17. The 2013 ACC/AHA guidelines on the treatment of blood cholesterol: questions, questions, questions.
Ginsberg HN
Circ Res; 2014 Feb; 114(5):761-4. PubMed ID: 24577964
[No Abstract] [Full Text] [Related]
18. [Interpretation of 2019 American College of Cardiology/American Heart Association guidelines on the primary prevention of cardiovascular disease].
Zhang XF; Hu DY
Zhonghua Nei Ke Za Zhi; 2020 Apr; 59(4):259-263. PubMed ID: 32209189
[TBL] [Abstract][Full Text] [Related]
19. [The Role of non-Statin Therapy for Lowering the Concentration of low-Density Lipoprotein Cholesterol and Reducing the Risk of Developing Atherosclerotic Cardiovascular Complications].
Konstantinov VO
Kardiologiia; 2017 May; 57(5):68-72. PubMed ID: 28762924
[TBL] [Abstract][Full Text] [Related]
20. What the guidelines do not say: statin non-benefit groups.
Morris PB; McLain K
Curr Atheroscler Rep; 2015 Jan; 17(1):468. PubMed ID: 25404095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
